Davey, R T <br/><br/>
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection.  [electronic resource] 

 -  The Journal of infectious diseases  Apr 1999 
 - 849-58 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/314678  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--immunology<br/>Adult<br/>CD4 Lymphocyte Count<br/>Dose-Response Relationship, Drug<br/>Female<br/>Follow-Up Studies<br/>HIV-1<br/>Humans<br/>Injections, Subcutaneous<br/>Interleukin-2--administration & dosage<br/>Male<br/>Middle Aged